Which peptides are studied for sexual and reproductive health?
Short answer
8 profiles here are grouped under “Sexual and reproductive health”: 7 FDA-approved and 1 not FDA-approved.
Each entry below quotes its profile and links to the full answer there.
FDA-approved 7
FDA-approved as Vyleesi for HSDD in premenopausal women1,2
FDA-approved. Drugs@FDA lists Vyleesi with an original approval date of June 21, 2019, for HSDD in premenopausal women. The cited label has no boxed warning.1,2
Is bremelanotide FDA-approved? · Melanotan II vs Bremelanotide
FDA-approved as Lupron, Eligard, Vobrig and other leuprolide products11,12,13,14,15,16
FDA-approved. Drugs@FDA lists Lupron with an original approval date of April 9, 1985, and Eligard with one of January 23, 2002, among many leuprolide applications. The cited Eligard label has no boxed warning.11,12,14
Is leuprolide FDA-approved? · Leuprolide vs Triptorelin · Goserelin vs Leuprolide
Not FDA-approved 1
PeptideScanner reports what the cited sources say. It is not medical advice and does not recommend using, buying or dosing any substance. Read the full disclaimer.
Citations
Sources
Numbered markers in the text point here. Each link opens the original public record.
- 1VYLEESI (bremelanotide) injection · SPL version 1 · published 2025-11-18 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked July 22, 2026
- 2Drugs@FDA application NDA210557 · original submission status AP · 2019-06-21 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 3CETROTIDE (cetrorelix acetate) kit · SPL version 18 · published 2025-09-29 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 4Drugs@FDA: CETROTIDE (cetrorelix acetate), NDA 021197 · original approval August 11, 2000 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 5Ganirelix acetate injection, solution (Organon LLC) · SPL version 10 · published 2026-10-12 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 6Drugs@FDA: Ganirelix acetate (Organon), NDA 021057 · original approval July 29, 1999 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 7Drugs@FDA: FACTREL (gonadorelin hydrochloride), NDA 018123 · original approval September 30, 1982 ↗
U.S. Food and Drug Administration · Official source · Source checked November 16, 2026
- 8Drugs@FDA: LUTREPULSE KIT (gonadorelin acetate), NDA 019687 · original approval October 10, 1989 ↗
U.S. Food and Drug Administration · Official source · Source checked November 16, 2026
- 9ZOLADEX (goserelin) implant · SPL version 9 · published 2026-03-26 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 10Drugs@FDA: ZOLADEX (goserelin acetate), NDA 019726 · original approval December 29, 1989 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 11ELIGARD (leuprolide acetate) injection, suspension, extended release · SPL version 19 · published 2026-05-11 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 12Drugs@FDA application NDA019010 · original submission status AP · 1985-04-09 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 13Drugs@FDA application NDA019732 · original submission status AP · 1989-01-26 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 14Drugs@FDA application NDA021343 · original submission status AP · 2002-01-23 · dataset 2026-08-13 ↗
Drugs@FDA via openFDA · Official source · Source checked August 14, 2026
- 15Vobrig (leuprolide acetate): NDA 213225 approval letter, August 26, 2026 ↗
U.S. Food and Drug Administration · Official source · Source checked November 14, 2026
- 16Drugs@FDA application NDA213225 · original submission status AP · 2026-08-26 · dataset 2026-11-13 ↗
Drugs@FDA via openFDA · Official source · Source checked November 15, 2026
- 17SYNAREL (nafarelin acetate) nasal solution · SPL version 23 · published 2026-03-10 ↗
DailyMed · U.S. National Library of Medicine · Official source · Source checked November 15, 2026
- 18Drugs@FDA: SYNAREL (nafarelin acetate), NDA 019886 · original approval February 13, 1990 ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 19FDA evaluation of kisspeptin-10, July 5, 2024 (briefing document for the October 29, 2024 Pharmacy Compounding Advisory Committee) ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 20October 29, 2024 Meeting of the Pharmacy Compounding Advisory Committee · minutes ↗
U.S. Food and Drug Administration · Official source · Source checked November 15, 2026
- 21Certain bulk drug substances for use in compounding that may present significant safety risks ↗
U.S. Food and Drug Administration · Official source · Source checked November 14, 2026